Marek Kovar

14PUBLICATIONS
70CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmaceutical delivery technologiesSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 17, 2026
NKG2A inhibition promotes NK cell-CD8+ T cell interactions to improve anticancer immunity in ovarian carcinoma.

|Jan 19, 2026
Lopinavir Derivative as Potent P-gp Inhibitor Enables Delivery through HPMA Copolymer Conjugates and Overcoming Tumor Chemoresistance to Conventional Cytostatic Drugs.

Daniil Starenko, Libor Kostka, Katerina Behalova

|Nov 27, 2025
Stimuli-Sensitive Platinum-Based Anticancer Polymer Therapeutics: Synthesis and Evaluation In Vitro.

Kateřina Běhalová, Martin Studenovský, Kevin Kotalík

|Aug 11, 2025
Temporal optimization of CD25-biased IL-2 agonists and immune checkpoint blockade leads to synergistic anticancer activity despite robust regulatory T cell expansion.

Irfan Baki Kilic, Petra Weberova, Derek VanDyke

|Apr 18, 2025
Novel PD-1-targeted, activity-optimized IL-15 mutein SOT201 acting in cis provides antitumor activity superior to PD1-IL2v.

Hana Matuskova, Pavel Marasek, Vladyslav Mazhara

|Dec 11, 2024
Dual Thermo- and pH-Responsive Polymer Nanoparticle Assemblies for Potential Stimuli-Controlled Drug Delivery.

Sára Pytlíková, Rafal Konefał, Robert Pola

Pageof 3

Frequent Collaborators

5 joint publications

Tomáš Etrych

3 joint publications

Jitka Fucikova

3 joint publications

Francis Jacob

3 joint publications

Sandra Orsulic